Notícias

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Jabil has rallied the Dow over the past year, and analysts remain highly bullish about the stock’s outlook.

SpaceX's sky-high valuation leaves very little room for positive returns in the near term.

Warner Bros. (WBD) unit CNN, Versant Media (VSNT) unit MS Now, and Politico's ban from the White Hou

Under the arrangement, Gopuff will become part of the Instacart Marketplace and will use Carrot Ads to run advertising on its own online storefront.

The Commerce Department secretary and the firm he used to run, Cantor Fitzgerald, placed big bets on USA Rare Earth’s unproven assets.

Apple’s iPhones, for example, are projected by Wall Street analysts to generate 17% more revenue this calendar year, according to FactSet. The main reason for the disconnect between sales and revenue are memory chip prices, which are being driven higher by the AI race.

Halozyme Therapeutics (HALO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

U. S. stock futures moved slightly higher on Wednesday as investors monitored developments around Meta Platforms’ (NASDAQ:META) Muse AI agent, Middle East diplomacy and upcoming U.

Michael Saylor’s Strategy repurchased 1.77 million STRC shares for $174 million, taking its combined Bitcoin and STRC spend to nearly $250 million for the week.

Sandisk led the S&P 500 higher last year, and it's once again the best-performing stock in the index this year.

The partnership will enable agentic checkout via Shop Pay across the platform's full roster of stores.

The Oracle of Omaha’s protégé is finding deals aplenty in one overseas market.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Palantir is up nearly 2,700% from its low and has emerged as a leading SaaS stock.

These are among the highest-yielding stocks on the S&P 500.

Energy markets are on edge as the Iran conflict disrupts oil supply, and the Federal Reserve keeps lifting interest rates to fight stubborn inflation. Power that is not tied to fossil fuels suddenly matters more to Canadian investors. Nuclear-focused companies sit squarely in that conversation. This article walks through three nuclear energy stocks from the Canadian market that can help you study this theme in a focused and time efficient way. The three nuclear energy stocks covered below are...

D-Wave Quantum (QBTS) has just added veteran financial technology executive Bernard Gavgani to its Board of Directors and Cybersecurity Committee, giving investors a fresh governance angle to assess alongside recent insider selling trends. Recent trading tells a mixed story for D-Wave Quantum. The share price is down 37.58% year to date and 23.59% over 90 days. However, the 7 day share price return of 7.01% hints at short term momentum within a much weaker long term trend, even after a very...

Equinor recently awarded SLB a contract to expand real-time leak detection, virtual flow metering and digital production monitoring across the Johan Sverdrup Phase 3 development in the North Sea, while Invictus Energy selected SLB for drilling and well services at the Musuma-1 exploration well in Zimbabwe. Together, these awards highlight growing adoption of SLB’s digital and high-end drilling technologies across both mature offshore hubs and frontier onshore basins. We’ll now examine how...

Lagging behind the Nasdaq Composite over the past year, analyst confidence in Snap-on remains somewhat bullish.

Biogen (BIIB) is back in focus after publishing adolescent subgroup data from its Phase 3 VALIANT trial of EMPAVELI in rare kidney diseases, a catalyst that gives investors fresh clinical context around the stock. For context, Biogen’s recent clinical and product news has landed against a backdrop of stronger trading action, with a 1-day share price return of 2.87% on the latest close at US$225.36 and a 90-day share price return of 12.91%. Investors are weighing kidney and Alzheimer’s updates...

Pfizer has quietly put together a 23.9% gain over the past year, and that kind of move invites a closer look at whether the current share price lines up with what its earnings can support. With the stock recently closing at US$27.93, the question is how much of the latest news and revenue mix shifts are already reflected in that figure. The 23.9% 1 year return has reset expectations for Pfizer, which puts more weight on whether its earnings base can carry that higher price level. Fresh...

Micron Technology has turned into one of the market's most eye catching semiconductor stories. The real question for anyone looking at the stock today is whether the current price can be squared with the earnings that sit behind it. After a powerful multi year run and a stream of headline grabbing developments, the key issue now is what investors are actually paying for in terms of profits. Over the past 3 years Micron Technology has delivered a very large share price gain of about 15x. That...

AbbVie (NYSE:ABBV) received European Commission approval for RINVOQ in polyarticular juvenile idiopathic arthritis for patients as young as two. Allergan Aesthetics launched AA Signature SKIN360 in the U.S., offering a multimodal digital platform for medical aesthetics consultations. AbbVie entered AI-focused collaborations with Iambic and the AISB Bind project to use advanced models in drug discovery and molecular binding prediction. The RINVOQ pediatric extension, AA Signature SKIN360...

Ryax’s technology will be integrated into Nutanix’s NKP and NAI platforms, aiming to optimise GPU use and streamline AI deployments.

Treasury bond yields have surged to levels last seen before the S&P 500 entered a deep bear market in 2007.

The hot IPO stock is finally delivering for shareholders.

Buffett has warned about "casino-type markets" for decades. The numbers say he's never been more right.

General Motors (NYSE:GM) Chief Financial Officer Paul Jacobson said the automaker remains on track to finish 2026 near the higher end of its full-year guidance after raising its outlook twice this year, citing continued consumer resilience, disciplined inventory management and a broad vehicle portfo

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.